metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P- 73 ULTRASOUND VISUALIZATION OF THE LIVER
Información de la revista
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Acceso a texto completo
P- 73 ULTRASOUND VISUALIZATION OF THE LIVER
Visitas
219
Ezequiel Demirdjian1, Diego Arufe1, Mariana Moreyra1, Guillermo Troiani2, Analia Cellerino2, Diego Costa3, Maria Pia Raffa1
1 Department of Liver Transplantation, Holy Heart Sanatory, CABA, Argentina
2 Department of Radiology, Holy Heart Sanatory, CABA, Argentina
3 Department of Cardiology, Holy Heart Sanatory, CABA, Argentina
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Tablas (1)
Suplemento especial
Este artículo forma parte de:
Vol. 28. Núm S1

Abstracts of the 2022 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Screening patients with liver cirrhosis for the detection of hepatocarcinoma is a daily challenge. Abdominal Doppler ultrasound has moderate sensitivity, as observed so far in published studies. The characterization of the liver visualization obtained can play an important role in determining its diagnostic capacity. This study aimed to evaluate the degree of liver visualization according to the US-LiRads system in patients with liver cirrhosis.

Materials and Methods

Prospective descriptive study of patients in the Hepatology service of the Holy Heart Sanatory from October 2018 to May 2022. One hundred-one patients with liver cirrhosis were evaluated by ultrasound during the usual follow-up of the service, collecting and characterizing laboratory data, body mass index (BMI), cause of cirrhosis and ultrasound (Ascites). Liver visualization was characterized according to the US-LiRads system. It classifies into Visualization A (no or minimal limitations), Visualization B (moderate limitations), and Visualization C (severe limitations. A statistical analysis was carried out to determine if these factors influence the degree of visualization, comparing the continuous variables with the Student's t test and the categorical ones with the chi-square test. A p value less than 0.05 was considered statistically significant.

Results

101 patients evaluated, we have documented that 68.3% present Visualization A, 28.7% Visualization B and the remaining 3% Visualization C (figure 1). We were unable to detect an association between age, cause of cirrhosis, sex, BMI, or presence of ascites with the degree of visualization (Table 1).

Conclusions

We can assert that liver Doppler ultrasound continues to be an acceptable method of screening since most patients present acceptable liver visualization. It was not observed that the patient's own factors affect liver Visualization. It would be necessary to carry out future studies to determine how less liver visualization affects screening.

Texto completo

Table 1. Characterization of the liver visualization and Associations

Visualization  p-value
69  29 
Age (years)  51.19 (11.84)  53.10 (12.74)  43.33 (21.08)  0.401 
Cause (%)        0.702
Primary Biliary Cholangitis  3 (4.3)  4 (13.8)  0 (0.0) 
Secondary Biliary Cholangitis  0 (0.0)  1 (3.4)  0 (0.0) 
Primary Sclerosing Cholangitis  2 (2.9)  0 (0.0)  0 (0.0) 
Criptogénic  1 (1.4)  0 (0.0)  0 (0.0) 
Autoimmune Hepatitis  14 (20.3)  10 (34.5)  1 (33.3) 
Hepatitis B  1 (1.4)  0 (0.0)  0 (0.0) 
Hepatitis C  17 (24.6)  5 (17.2)  0 (0.0) 
NAFLD  14 (20.3)  6 (20.7)  1 (33.3) 
Alcoholic Cirrhosis  17 (24.6)  3 (10.3)  1 (33.3) 
Ascites (%)        0.238
Absent  50 (72.5)  18 (62.1)  1 (33.3) 
Mild  10 (14.5)  4 (13.8)  2 (66.7) 
Moderate  5 (7.2)  4 (13.8)  0 (0.0) 
Severe  4 (5.8)  3 (10.3)  0 (0.0) 
Male Gender(%)  27 (39.1)  13 (44.8)  1 (33.3)  0.843 
BMI (kg/m227.80 (4.56)  29.70 (5.96)  28.80 (7.63)  0.240 

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos